Taxus shelf-life amended
This article was originally published in The Gray Sheet
Executive Summary
FDA extends the approved shelf-life of Boston Scientific's Taxus paclitaxel-eluting stent from six to nine months, the company announces Aug. 19. The amendment is based on data showing that "the drug content, drug degradation profile and drug-release mechanism [were] maintained within FDA-approved specifications at nine months," Boston Scientific explains...